Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Rakesh K Srivastava
|Rakesh K Srivastava
Kansas Medical Center
Dr. Rakesh K. Srivastava is a Professor in Cancer Research and KBA Eminent Scholar in University of Guelph, Ontario, Canada
Cancer biology, angiogenesis, metastasis, transgenic animals, stem cells, biomarkers, transcription factors, drug discovery and development. The main focus of my laboratory is to examine the molecular mechanisms of apoptosis, angiogenesis and metastasis, and develop novel drugs for the treatment and prevention of various cancers.
We have used biochemical, molecular and transgenic animal approaches to identify novel death receptor agonists. These small molecules bind to death receptors and induce apoptosis in cancer cells, while sparing normal cells. Inhibition of survival pathways have been shown to enhance the therapeutic potential of death receptor agonists.
Global Speakers in the subject
Global Experts in the subject